▶ 調査レポート

世界の関節リウマチ（RA）治療薬市場規模・現状・予測（2021年-2027年）
• 英文タイトル：Global Rheumatoid Arthritis (RA) Drugs Market Size, Status and Forecast 2021-2027

Global Rheumatoid Arthritis (RA) Drugs Market Size, Status and Forecast 2021-2027「世界の関節リウマチ（RA）治療薬市場規模・現状・予測（2021年-2027年）」（市場規模、市場予測）調査レポートです。• レポートコード：QYR2104Z5043
• 出版社/出版日：QYResearch / 2021年4月10日
• レポート形態：英文、PDF、90ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療
• 販売価格（消費税別）
  Single User￥577,200 (USD3,900)▷ お問い合わせ
  Multi User/Five User￥865,800 (USD5,850)▷ お問い合わせ
  Enterprise License（同一法人内共有可）￥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
QYResearch社発行の本調査資料では、関節リウマチ（RA）治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（NSAID、鎮痛薬、副腎皮質ステロイド、DMARD、生物学的療法、JAK阻害剤）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・関節リウマチ（RA）治療薬の市場動向
・企業の競争状況、市場シェア
・関節リウマチ（RA）治療薬の種類別市場規模（NSAID、鎮痛薬、副腎皮質ステロイド、DMARD、生物学的療法、JAK阻害剤）
・関節リウマチ（RA）治療薬の用途別市場規模（病院、診療所、その他）
・関節リウマチ（RA）治療薬の北米市場規模2016-2027（アメリカ、カナダ）
・関節リウマチ（RA）治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・関節リウマチ（RA）治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・関節リウマチ（RA）治療薬の中南米市場規模2016-2027（メキシコ、ブラジル）
・関節リウマチ（RA）治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（AbbVie、Roche、Merck、HEYL Chemisch-pharmazeutische Fabrik、Johnson & Johnson、Amgen, Inc.、Pfizer、Bristol-Myers Squibb、UCB、GSK、Sanofi、Abbott Laboratories、Teva Pharmaceutical）
・結論

Rheumatoid arthritis (RA) is an inflammatory disease that progresses over time affecting the joints. The symptoms aggravate over time, which is why medication for RA becomes essential to stop the inflammation. There is no permanent cure for rheumatoid arthritis, though increasing research activities regarding the same indicate that remission of symptoms is achieved when treatment begins in the initial stages with strong medications known as disease-modifying antirheumatic drugs (DMARDs).

Market Analysis and Insights: Global Rheumatoid Arthritis (RA) Drugs Market
The global Rheumatoid Arthritis (RA) Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Rheumatoid Arthritis (RA) Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Rheumatoid Arthritis (RA) Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Rheumatoid Arthritis (RA) Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Rheumatoid Arthritis (RA) Drugs market.

Global Rheumatoid Arthritis (RA) Drugs Scope and Market Size
Rheumatoid Arthritis (RA) Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Rheumatoid Arthritis (RA) Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
NSAIDs
Analgesic Drugs
Corticosteroids
DMARDs
Biological Therapies
JAK-inhibitors

Segment by Application
Hospitals
Clinics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AbbVie
Roche
Merck
HEYL Chemisch-pharmazeutische Fabrik
Johnson & Johnson
Amgen, Inc.
Pfizer
Bristol-Myers Squibb
UCB
HEYL Chemisch-pharmazeutische Fabrik
Johnson & Johnson

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Rheumatoid Arthritis (RA) Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 NSAIDs
1.2.3 Analgesic Drugs
1.2.4 Corticosteroids
1.2.5 DMARDs
1.2.6 Biological Therapies
1.2.7 JAK-inhibitors
1.3 Market by Application
1.3.1 Global Rheumatoid Arthritis (RA) Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Rheumatoid Arthritis (RA) Drugs Market Perspective (2016-2027)
2.2 Rheumatoid Arthritis (RA) Drugs Growth Trends by Regions
2.2.1 Rheumatoid Arthritis (RA) Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Rheumatoid Arthritis (RA) Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Rheumatoid Arthritis (RA) Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Rheumatoid Arthritis (RA) Drugs Industry Dynamic
2.3.1 Rheumatoid Arthritis (RA) Drugs Market Trends
2.3.2 Rheumatoid Arthritis (RA) Drugs Market Drivers
2.3.3 Rheumatoid Arthritis (RA) Drugs Market Challenges
2.3.4 Rheumatoid Arthritis (RA) Drugs Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Rheumatoid Arthritis (RA) Drugs Players by Revenue
3.1.1 Global Top Rheumatoid Arthritis (RA) Drugs Players by Revenue (2016-2021)
3.1.2 Global Rheumatoid Arthritis (RA) Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Rheumatoid Arthritis (RA) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Rheumatoid Arthritis (RA) Drugs Revenue
3.4 Global Rheumatoid Arthritis (RA) Drugs Market Concentration Ratio
3.4.1 Global Rheumatoid Arthritis (RA) Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Rheumatoid Arthritis (RA) Drugs Revenue in 2020
3.5 Rheumatoid Arthritis (RA) Drugs Key Players Head office and Area Served
3.6 Key Players Rheumatoid Arthritis (RA) Drugs Product Solution and Service
3.7 Date of Enter into Rheumatoid Arthritis (RA) Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Rheumatoid Arthritis (RA) Drugs Breakdown Data by Type
4.1 Global Rheumatoid Arthritis (RA) Drugs Historic Market Size by Type (2016-2021)
4.2 Global Rheumatoid Arthritis (RA) Drugs Forecasted Market Size by Type (2022-2027)

5 Rheumatoid Arthritis (RA) Drugs Breakdown Data by Application
5.1 Global Rheumatoid Arthritis (RA) Drugs Historic Market Size by Application (2016-2021)
5.2 Global Rheumatoid Arthritis (RA) Drugs Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Rheumatoid Arthritis (RA) Drugs Market Size (2016-2027)
6.2 North America Rheumatoid Arthritis (RA) Drugs Market Size by Type
6.2.1 North America Rheumatoid Arthritis (RA) Drugs Market Size by Type (2016-2021)
6.2.2 North America Rheumatoid Arthritis (RA) Drugs Market Size by Type (2022-2027)
6.2.3 North America Rheumatoid Arthritis (RA) Drugs Market Size by Type (2016-2027)
6.3 North America Rheumatoid Arthritis (RA) Drugs Market Size by Application
6.3.1 North America Rheumatoid Arthritis (RA) Drugs Market Size by Application (2016-2021)
6.3.2 North America Rheumatoid Arthritis (RA) Drugs Market Size by Application (2022-2027)
6.3.3 North America Rheumatoid Arthritis (RA) Drugs Market Size by Application (2016-2027)
6.4 North America Rheumatoid Arthritis (RA) Drugs Market Size by Country
6.4.1 North America Rheumatoid Arthritis (RA) Drugs Market Size by Country (2016-2021)
6.4.2 North America Rheumatoid Arthritis (RA) Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Rheumatoid Arthritis (RA) Drugs Market Size (2016-2027)
7.2 Europe Rheumatoid Arthritis (RA) Drugs Market Size by Type
7.2.1 Europe Rheumatoid Arthritis (RA) Drugs Market Size by Type (2016-2021)
7.2.2 Europe Rheumatoid Arthritis (RA) Drugs Market Size by Type (2022-2027)
7.2.3 Europe Rheumatoid Arthritis (RA) Drugs Market Size by Type (2016-2027)
7.3 Europe Rheumatoid Arthritis (RA) Drugs Market Size by Application
7.3.1 Europe Rheumatoid Arthritis (RA) Drugs Market Size by Application (2016-2021)
7.3.2 Europe Rheumatoid Arthritis (RA) Drugs Market Size by Application (2022-2027)
7.3.3 Europe Rheumatoid Arthritis (RA) Drugs Market Size by Application (2016-2027)
7.4 Europe Rheumatoid Arthritis (RA) Drugs Market Size by Country
7.4.1 Europe Rheumatoid Arthritis (RA) Drugs Market Size by Country (2016-2021)
7.4.2 Europe Rheumatoid Arthritis (RA) Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Rheumatoid Arthritis (RA) Drugs Market Size (2016-2027)
8.2 Asia-Pacific Rheumatoid Arthritis (RA) Drugs Market Size by Type
8.2.1 Asia-Pacific Rheumatoid Arthritis (RA) Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Rheumatoid Arthritis (RA) Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Rheumatoid Arthritis (RA) Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Rheumatoid Arthritis (RA) Drugs Market Size by Application
8.3.1 Asia-Pacific Rheumatoid Arthritis (RA) Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Rheumatoid Arthritis (RA) Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Rheumatoid Arthritis (RA) Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Rheumatoid Arthritis (RA) Drugs Market Size by Region
8.4.1 Asia-Pacific Rheumatoid Arthritis (RA) Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Rheumatoid Arthritis (RA) Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Rheumatoid Arthritis (RA) Drugs Market Size (2016-2027)
9.2 Latin America Rheumatoid Arthritis (RA) Drugs Market Size by Type
9.2.1 Latin America Rheumatoid Arthritis (RA) Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Rheumatoid Arthritis (RA) Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Rheumatoid Arthritis (RA) Drugs Market Size by Type (2016-2027)
9.3 Latin America Rheumatoid Arthritis (RA) Drugs Market Size by Application
9.3.1 Latin America Rheumatoid Arthritis (RA) Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Rheumatoid Arthritis (RA) Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Rheumatoid Arthritis (RA) Drugs Market Size by Application (2016-2027)
9.4 Latin America Rheumatoid Arthritis (RA) Drugs Market Size by Country
9.4.1 Latin America Rheumatoid Arthritis (RA) Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Rheumatoid Arthritis (RA) Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Rheumatoid Arthritis (RA) Drugs Market Size (2016-2027)
10.2 Middle East & Africa Rheumatoid Arthritis (RA) Drugs Market Size by Type
10.2.1 Middle East & Africa Rheumatoid Arthritis (RA) Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Rheumatoid Arthritis (RA) Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Rheumatoid Arthritis (RA) Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Rheumatoid Arthritis (RA) Drugs Market Size by Application
10.3.1 Middle East & Africa Rheumatoid Arthritis (RA) Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Rheumatoid Arthritis (RA) Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Rheumatoid Arthritis (RA) Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Rheumatoid Arthritis (RA) Drugs Market Size by Country
10.4.1 Middle East & Africa Rheumatoid Arthritis (RA) Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Rheumatoid Arthritis (RA) Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Rheumatoid Arthritis (RA) Drugs Introduction
11.1.4 AbbVie Revenue in Rheumatoid Arthritis (RA) Drugs Business (2016-2021)
11.1.5 AbbVie Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Rheumatoid Arthritis (RA) Drugs Introduction
11.2.4 Roche Revenue in Rheumatoid Arthritis (RA) Drugs Business (2016-2021)
11.2.5 Roche Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Rheumatoid Arthritis (RA) Drugs Introduction
11.3.4 Merck Revenue in Rheumatoid Arthritis (RA) Drugs Business (2016-2021)
11.3.5 Merck Recent Development
11.4 HEYL Chemisch-pharmazeutische Fabrik
11.4.1 HEYL Chemisch-pharmazeutische Fabrik Company Details
11.4.2 HEYL Chemisch-pharmazeutische Fabrik Business Overview
11.4.3 HEYL Chemisch-pharmazeutische Fabrik Rheumatoid Arthritis (RA) Drugs Introduction
11.4.4 HEYL Chemisch-pharmazeutische Fabrik Revenue in Rheumatoid Arthritis (RA) Drugs Business (2016-2021)
11.4.5 HEYL Chemisch-pharmazeutische Fabrik Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Rheumatoid Arthritis (RA) Drugs Introduction
11.5.4 Johnson & Johnson Revenue in Rheumatoid Arthritis (RA) Drugs Business (2016-2021)
11.5.5 Johnson & Johnson Recent Development
11.6 Amgen, Inc.
11.6.1 Amgen, Inc. Company Details
11.6.2 Amgen, Inc. Business Overview
11.6.3 Amgen, Inc. Rheumatoid Arthritis (RA) Drugs Introduction
11.6.4 Amgen, Inc. Revenue in Rheumatoid Arthritis (RA) Drugs Business (2016-2021)
11.6.5 Amgen, Inc. Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Rheumatoid Arthritis (RA) Drugs Introduction
11.7.4 Pfizer Revenue in Rheumatoid Arthritis (RA) Drugs Business (2016-2021)
11.7.5 Pfizer Recent Development
11.8 Bristol-Myers Squibb
11.8.1 Bristol-Myers Squibb Company Details
11.8.2 Bristol-Myers Squibb Business Overview
11.8.3 Bristol-Myers Squibb Rheumatoid Arthritis (RA) Drugs Introduction
11.8.4 Bristol-Myers Squibb Revenue in Rheumatoid Arthritis (RA) Drugs Business (2016-2021)
11.8.5 Bristol-Myers Squibb Recent Development
11.9 UCB
11.9.1 UCB Company Details
11.9.2 UCB Business Overview
11.9.3 UCB Rheumatoid Arthritis (RA) Drugs Introduction
11.9.4 UCB Revenue in Rheumatoid Arthritis (RA) Drugs Business (2016-2021)
11.9.5 UCB Recent Development
11.10 GSK
11.10.1 GSK Company Details
11.10.2 GSK Business Overview
11.10.3 GSK Rheumatoid Arthritis (RA) Drugs Introduction
11.10.4 GSK Revenue in Rheumatoid Arthritis (RA) Drugs Business (2016-2021)
11.10.5 GSK Recent Development
11.11 Sanofi
11.11.1 Sanofi Company Details
11.11.2 Sanofi Business Overview
11.11.3 Sanofi Rheumatoid Arthritis (RA) Drugs Introduction
11.11.4 Sanofi Revenue in Rheumatoid Arthritis (RA) Drugs Business (2016-2021)
11.11.5 Sanofi Recent Development
11.12 Abbott Laboratories
11.12.1 Abbott Laboratories Company Details
11.12.2 Abbott Laboratories Business Overview
11.12.3 Abbott Laboratories Rheumatoid Arthritis (RA) Drugs Introduction
11.12.4 Abbott Laboratories Revenue in Rheumatoid Arthritis (RA) Drugs Business (2016-2021)
11.12.5 Abbott Laboratories Recent Development
11.13 Teva Pharmaceutical
11.13.1 Teva Pharmaceutical Company Details
11.13.2 Teva Pharmaceutical Business Overview
11.13.3 Teva Pharmaceutical Rheumatoid Arthritis (RA) Drugs Introduction
11.13.4 Teva Pharmaceutical Revenue in Rheumatoid Arthritis (RA) Drugs Business (2016-2021)
11.13.5 Teva Pharmaceutical Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Rheumatoid Arthritis (RA) Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of NSAIDs
Table 3. Key Players of Analgesic Drugs
Table 4. Key Players of Corticosteroids
Table 5. Key Players of DMARDs
Table 6. Key Players of Biological Therapies
Table 7. Key Players of JAK-inhibitors
Table 8. Global Rheumatoid Arthritis (RA) Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Rheumatoid Arthritis (RA) Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Rheumatoid Arthritis (RA) Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Rheumatoid Arthritis (RA) Drugs Market Share by Regions (2016-2021)
Table 12. Global Rheumatoid Arthritis (RA) Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Rheumatoid Arthritis (RA) Drugs Market Share by Regions (2022-2027)
Table 14. Rheumatoid Arthritis (RA) Drugs Market Trends
Table 15. Rheumatoid Arthritis (RA) Drugs Market Drivers
Table 16. Rheumatoid Arthritis (RA) Drugs Market Challenges
Table 17. Rheumatoid Arthritis (RA) Drugs Market Restraints
Table 18. Global Rheumatoid Arthritis (RA) Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Rheumatoid Arthritis (RA) Drugs Market Share by Players (2016-2021)
Table 20. Global Top Rheumatoid Arthritis (RA) Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rheumatoid Arthritis (RA) Drugs as of 2020)
Table 21. Ranking of Global Top Rheumatoid Arthritis (RA) Drugs Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Rheumatoid Arthritis (RA) Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Rheumatoid Arthritis (RA) Drugs Product Solution and Service
Table 25. Date of Enter into Rheumatoid Arthritis (RA) Drugs Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Rheumatoid Arthritis (RA) Drugs Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Rheumatoid Arthritis (RA) Drugs Revenue Market Share by Type (2016-2021)
Table 29. Global Rheumatoid Arthritis (RA) Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Rheumatoid Arthritis (RA) Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Rheumatoid Arthritis (RA) Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Rheumatoid Arthritis (RA) Drugs Revenue Market Share by Application (2016-2021)
Table 33. Global Rheumatoid Arthritis (RA) Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Rheumatoid Arthritis (RA) Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Rheumatoid Arthritis (RA) Drugs Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Rheumatoid Arthritis (RA) Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Rheumatoid Arthritis (RA) Drugs Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Rheumatoid Arthritis (RA) Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Rheumatoid Arthritis (RA) Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Rheumatoid Arthritis (RA) Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Rheumatoid Arthritis (RA) Drugs Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Rheumatoid Arthritis (RA) Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Rheumatoid Arthritis (RA) Drugs Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Rheumatoid Arthritis (RA) Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Rheumatoid Arthritis (RA) Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Rheumatoid Arthritis (RA) Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Rheumatoid Arthritis (RA) Drugs Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Rheumatoid Arthritis (RA) Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Rheumatoid Arthritis (RA) Drugs Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Rheumatoid Arthritis (RA) Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Rheumatoid Arthritis (RA) Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Rheumatoid Arthritis (RA) Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Rheumatoid Arthritis (RA) Drugs Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Rheumatoid Arthritis (RA) Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Rheumatoid Arthritis (RA) Drugs Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Rheumatoid Arthritis (RA) Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Rheumatoid Arthritis (RA) Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Rheumatoid Arthritis (RA) Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Rheumatoid Arthritis (RA) Drugs Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Rheumatoid Arthritis (RA) Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Rheumatoid Arthritis (RA) Drugs Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Rheumatoid Arthritis (RA) Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Rheumatoid Arthritis (RA) Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Rheumatoid Arthritis (RA) Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 65. AbbVie Company Details
Table 66. AbbVie Business Overview
Table 67. AbbVie Rheumatoid Arthritis (RA) Drugs Product
Table 68. AbbVie Revenue in Rheumatoid Arthritis (RA) Drugs Business (2016-2021) & (US$ Million)
Table 69. AbbVie Recent Development
Table 70. Roche Company Details
Table 71. Roche Business Overview
Table 72. Roche Rheumatoid Arthritis (RA) Drugs Product
Table 73. Roche Revenue in Rheumatoid Arthritis (RA) Drugs Business (2016-2021) & (US$ Million)
Table 74. Roche Recent Development
Table 75. Merck Company Details
Table 76. Merck Business Overview
Table 77. Merck Rheumatoid Arthritis (RA) Drugs Product
Table 78. Merck Revenue in Rheumatoid Arthritis (RA) Drugs Business (2016-2021) & (US$ Million)
Table 79. Merck Recent Development
Table 80. HEYL Chemisch-pharmazeutische Fabrik Company Details
Table 81. HEYL Chemisch-pharmazeutische Fabrik Business Overview
Table 82. HEYL Chemisch-pharmazeutische Fabrik Rheumatoid Arthritis (RA) Drugs Product
Table 83. HEYL Chemisch-pharmazeutische Fabrik Revenue in Rheumatoid Arthritis (RA) Drugs Business (2016-2021) & (US$ Million)
Table 84. HEYL Chemisch-pharmazeutische Fabrik Recent Development
Table 85. Johnson & Johnson Company Details
Table 86. Johnson & Johnson Business Overview
Table 87. Johnson & Johnson Rheumatoid Arthritis (RA) Drugs Product
Table 88. Johnson & Johnson Revenue in Rheumatoid Arthritis (RA) Drugs Business (2016-2021) & (US$ Million)
Table 89. Johnson & Johnson Recent Development
Table 90. Amgen, Inc. Company Details
Table 91. Amgen, Inc. Business Overview
Table 92. Amgen, Inc. Rheumatoid Arthritis (RA) Drugs Product
Table 93. Amgen, Inc. Revenue in Rheumatoid Arthritis (RA) Drugs Business (2016-2021) & (US$ Million)
Table 94. Amgen, Inc. Recent Development
Table 95. Pfizer Company Details
Table 96. Pfizer Business Overview
Table 97. Pfizer Rheumatoid Arthritis (RA) Drugs Product
Table 98. Pfizer Revenue in Rheumatoid Arthritis (RA) Drugs Business (2016-2021) & (US$ Million)
Table 99. Pfizer Recent Development
Table 100. Bristol-Myers Squibb Company Details
Table 101. Bristol-Myers Squibb Business Overview
Table 102. Bristol-Myers Squibb Revenue in Rheumatoid Arthritis (RA) Drugs Business (2016-2021) & (US$ Million)
Table 103. Bristol-Myers Squibb Recent Development
Table 104. UCB Company Details
Table 105. UCB Business Overview
Table 106. UCB Rheumatoid Arthritis (RA) Drugs Product
Table 107. UCB Revenue in Rheumatoid Arthritis (RA) Drugs Business (2016-2021) & (US$ Million)
Table 108. UCB Recent Development
Table 109. GSK Company Details
Table 110. GSK Business Overview
Table 111. GSK Rheumatoid Arthritis (RA) Drugs Product
Table 112. GSK Revenue in Rheumatoid Arthritis (RA) Drugs Business (2016-2021) & (US$ Million)
Table 113. GSK Recent Development
Table 114. Sanofi Company Details
Table 115. Sanofi Business Overview
Table 116. Sanofi Rheumatoid Arthritis (RA) Drugs Product
Table 117. Sanofi Revenue in Rheumatoid Arthritis (RA) Drugs Business (2016-2021) & (US$ Million)
Table 118. Sanofi Recent Development
Table 119. Abbott Laboratories Company Details
Table 120. Abbott Laboratories Business Overview
Table 121. Abbott Laboratories Rheumatoid Arthritis (RA) Drugs Product
Table 122. Abbott Laboratories Revenue in Rheumatoid Arthritis (RA) Drugs Business (2016-2021) & (US$ Million)
Table 123. Abbott Laboratories Recent Development
Table 124. Teva Pharmaceutical Company Details
Table 125. Teva Pharmaceutical Business Overview
Table 126. Teva Pharmaceutical Rheumatoid Arthritis (RA) Drugs Product
Table 127. Teva Pharmaceutical Revenue in Rheumatoid Arthritis (RA) Drugs Business (2016-2021) & (US$ Million)
Table 128. Teva Pharmaceutical Recent Development
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Rheumatoid Arthritis (RA) Drugs Market Share by Type: 2020 VS 2027
Figure 2. NSAIDs Features
Figure 3. Analgesic Drugs Features
Figure 4. Corticosteroids Features
Figure 5. DMARDs Features
Figure 6. Biological Therapies Features
Figure 7. JAK-inhibitors Features
Figure 8. Global Rheumatoid Arthritis (RA) Drugs Market Share by Application: 2020 VS 2027
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Others Case Studies
Figure 12. Rheumatoid Arthritis (RA) Drugs Report Years Considered
Figure 13. Global Rheumatoid Arthritis (RA) Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Rheumatoid Arthritis (RA) Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Rheumatoid Arthritis (RA) Drugs Market Share by Regions: 2020 VS 2027
Figure 16. Global Rheumatoid Arthritis (RA) Drugs Market Share by Regions (2022-2027)
Figure 17. Global Rheumatoid Arthritis (RA) Drugs Market Share by Players in 2020
Figure 18. Global Top Rheumatoid Arthritis (RA) Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rheumatoid Arthritis (RA) Drugs as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Rheumatoid Arthritis (RA) Drugs Revenue in 2020
Figure 20. Global Rheumatoid Arthritis (RA) Drugs Revenue Market Share by Type (2016-2021)
Figure 21. Global Rheumatoid Arthritis (RA) Drugs Revenue Market Share by Type (2022-2027)
Figure 22. North America Rheumatoid Arthritis (RA) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Rheumatoid Arthritis (RA) Drugs Market Share by Type (2016-2027)
Figure 24. North America Rheumatoid Arthritis (RA) Drugs Market Share by Application (2016-2027)
Figure 25. North America Rheumatoid Arthritis (RA) Drugs Market Share by Country (2016-2027)
Figure 26. United States Rheumatoid Arthritis (RA) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Rheumatoid Arthritis (RA) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Rheumatoid Arthritis (RA) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Rheumatoid Arthritis (RA) Drugs Market Share by Type (2016-2027)
Figure 30. Europe Rheumatoid Arthritis (RA) Drugs Market Share by Application (2016-2027)
Figure 31. Europe Rheumatoid Arthritis (RA) Drugs Market Share by Country (2016-2027)
Figure 32. Germany Rheumatoid Arthritis (RA) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Rheumatoid Arthritis (RA) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Rheumatoid Arthritis (RA) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Rheumatoid Arthritis (RA) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Rheumatoid Arthritis (RA) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Rheumatoid Arthritis (RA) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Rheumatoid Arthritis (RA) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Rheumatoid Arthritis (RA) Drugs Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Rheumatoid Arthritis (RA) Drugs Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Rheumatoid Arthritis (RA) Drugs Market Share by Region (2016-2027)
Figure 42. China Rheumatoid Arthritis (RA) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Rheumatoid Arthritis (RA) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Rheumatoid Arthritis (RA) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Rheumatoid Arthritis (RA) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Rheumatoid Arthritis (RA) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Rheumatoid Arthritis (RA) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Rheumatoid Arthritis (RA) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Rheumatoid Arthritis (RA) Drugs Market Share by Type (2016-2027)
Figure 50. Latin America Rheumatoid Arthritis (RA) Drugs Market Share by Application (2016-2027)
Figure 51. Latin America Rheumatoid Arthritis (RA) Drugs Market Share by Country (2016-2027)
Figure 52. Mexico Rheumatoid Arthritis (RA) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Rheumatoid Arthritis (RA) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Rheumatoid Arthritis (RA) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Rheumatoid Arthritis (RA) Drugs Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Rheumatoid Arthritis (RA) Drugs Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Rheumatoid Arthritis (RA) Drugs Market Share by Country (2016-2027)
Figure 58. Turkey Rheumatoid Arthritis (RA) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Rheumatoid Arthritis (RA) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Rheumatoid Arthritis (RA) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. AbbVie Revenue Growth Rate in Rheumatoid Arthritis (RA) Drugs Business (2016-2021)
Figure 62. Roche Revenue Growth Rate in Rheumatoid Arthritis (RA) Drugs Business (2016-2021)
Figure 63. Merck Revenue Growth Rate in Rheumatoid Arthritis (RA) Drugs Business (2016-2021)
Figure 64. HEYL Chemisch-pharmazeutische Fabrik Revenue Growth Rate in Rheumatoid Arthritis (RA) Drugs Business (2016-2021)
Figure 65. Johnson & Johnson Revenue Growth Rate in Rheumatoid Arthritis (RA) Drugs Business (2016-2021)
Figure 66. Amgen, Inc. Revenue Growth Rate in Rheumatoid Arthritis (RA) Drugs Business (2016-2021)
Figure 67. Pfizer Revenue Growth Rate in Rheumatoid Arthritis (RA) Drugs Business (2016-2021)
Figure 68. Bristol-Myers Squibb Revenue Growth Rate in Rheumatoid Arthritis (RA) Drugs Business (2016-2021)
Figure 69. UCB Revenue Growth Rate in Rheumatoid Arthritis (RA) Drugs Business (2016-2021)
Figure 70. GSK Revenue Growth Rate in Rheumatoid Arthritis (RA) Drugs Business (2016-2021)
Figure 71. Sanofi Revenue Growth Rate in Rheumatoid Arthritis (RA) Drugs Business (2016-2021)
Figure 72. Abbott Laboratories Revenue Growth Rate in Rheumatoid Arthritis (RA) Drugs Business (2016-2021)
Figure 73. Teva Pharmaceutical Revenue Growth Rate in Rheumatoid Arthritis (RA) Drugs Business (2016-2021)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed

関連レポート
  • 住宅用ポータブル発電機のグローバル市場2021
    Global Residential Portable Generator Sales Market Report 2021
    QAF26380 2021年5月28日 148Pages
    本市場調査資料では、世界の住宅用ポータブル発電機市場について種類別（ディーゼルタイプ、ガソリンタイプ、ガスタイプ）、用途別（4 KW以下、4〜8 KW、8KW以上）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測...
  • 世界のフィードホーン市場 2028年：長方形、円形
    Global Feed Horn Market Insights, Forecast to 2028
    QY2207C1672 2022年7月8日 110Pages
    新型コロナウイルス感染症のパンデミックにより、世界のフィードホーンの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にフィードホーンの世界市...
  • 世界のボックス型変圧器変電所市場 2028年：定格電圧10kV以下、定格電圧10〜20kV、定格電圧20kV以上
    Global Box Type Transformer Substation Market Insights, Forecast to 2028
    QY2207C1943 2022年7月8日 113Pages
    新型コロナウイルス感染症のパンデミックにより、世界のボックス型変圧器変電所の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にボックス型変圧...
  • 世界のコンクリート検査システム市場 2028年：超音波探傷、CT検査
    Global Concrete Inspection System Market Insights, Forecast to 2028
    QY2207C3172 2022年7月11日 88Pages
    新型コロナウイルス感染症のパンデミックにより、世界のコンクリート検査システムの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にコンクリート...
  • 世界の電気モーターバルブアクチュエータ市場 2028年：ロータリー型、リニア型
    Global Electromotoric Valve Actuator Market Insights, Forecast to 2028
    QY2207C2335 2022年7月1日 105Pages
    新型コロナウイルス感染症のパンデミックにより、世界の電気モーターバルブアクチュエータの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に電気...
  • 米粉のグローバル市場2021
    Global Rice Flour Sales Market Report 2021
    QAF24875 2021年5月28日 134Pages
    本市場調査資料では、世界の米粉市場について種類別（米粉、玄米粉、もち米粉、その他）、用途別（ビーフン・ライスパスタ、スイーツ・デザート、スナック、パン、増粘剤）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販...
  • 抹茶のグローバル市場2021
    Global Matcha Tea Sales Market Report 2021
    QAF24799 2021年5月28日 137Pages
    本市場調査資料では、世界の抹茶市場について種類別（飲用抹茶、添加剤抹茶）、用途別（飲料用お茶、ペーストリー、アイスクリーム、飲料用）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレ...
  • ダブルブロック＆ブリードバルブのグローバル市場2021
    Global Double Block and Bleed Valves Sales Market Report 2021
    QAF25396 2021年5月28日 144Pages
    本市場調査資料では、世界のダブルブロック＆ブリードバルブ市場について種類別（フルボア、リデュースドボア）、用途別（石油＆ガス、化学工業、電力産業、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、...
  • トリプトファンのグローバル市場2021
    Global Tryptophan Sales Market Report 2021
    QAF22888 2021年5月28日 133Pages
    本市場調査資料では、世界のトリプトファン市場について種類別（98％トリプトファン、その他（99％、20％））、用途別（動物飼料、食品・飲料、医療）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価...
  • 世界の清澄剤市場 2028年：硫酸銅溶液、ベントナイト粉末、ゼラチン粉末、シリカゲル
    Global Fining Agent Market Insights, Forecast to 2028
    QY2207C0397 2022年7月15日 114Pages
    新型コロナウイルス感染症のパンデミックにより、世界の清澄剤の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に清澄剤の世界市場のxxx％を占...